2021-001627-40: A clinical study to investigate the efficacy of flecainide acetate inhalation solution on restoring the normal heart rhythm in patients with recent-onset, symptomatic atrial fibrillation. |
|
|
| Not yet recruiting | 3 | 400 | Europe, RoW | flecainide acetate, FlecIH-103, Inhalation solution | InCarda Therapeutics, Inc., InCarda Therapeutics, Inc. | Recent-onset symptomatic atrial fibrillation, Atrial fibrillation, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
RESTORE-1, NCT05039359: Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation |
|
|
| Terminated | 3 | 54 | Europe, US, RoW | FlecIH-103 | InCarda Therapeutics, Inc. | Paroxysmal Atrial Fibrillation | 05/23 | 05/23 | | |